SE407408B - Forfarande for framstellning av kondenserade kinozolinderivat - Google Patents

Forfarande for framstellning av kondenserade kinozolinderivat

Info

Publication number
SE407408B
SE407408B SE7310561A SE7310561A SE407408B SE 407408 B SE407408 B SE 407408B SE 7310561 A SE7310561 A SE 7310561A SE 7310561 A SE7310561 A SE 7310561A SE 407408 B SE407408 B SE 407408B
Authority
SE
Sweden
Prior art keywords
kinozoline
condensed
derivatives
procedure
preparation
Prior art date
Application number
SE7310561A
Other languages
English (en)
Swedish (sv)
Other versions
SE7310561L (en, 2012
Inventor
Jr W N Beverung
R A Partyka
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE7310561L publication Critical patent/SE7310561L/xx
Publication of SE407408B publication Critical patent/SE407408B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7310561A 1972-09-22 1973-07-31 Forfarande for framstellning av kondenserade kinozolinderivat SE407408B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29145072A 1972-09-22 1972-09-22

Publications (2)

Publication Number Publication Date
SE7310561L SE7310561L (en, 2012) 1974-03-25
SE407408B true SE407408B (sv) 1979-03-26

Family

ID=23120338

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7310561A SE407408B (sv) 1972-09-22 1973-07-31 Forfarande for framstellning av kondenserade kinozolinderivat

Country Status (6)

Country Link
CH (1) CH609348A5 (en, 2012)
DK (1) DK152367C (en, 2012)
FI (1) FI56012C (en, 2012)
HU (1) HU167227B (en, 2012)
NL (1) NL178165C (en, 2012)
SE (1) SE407408B (en, 2012)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598823A (en) * 1969-05-28 1971-08-10 Sandoz Ag Tricyclic quinazolinones
BE760013A (fr) * 1969-12-18 1971-06-08 Smith Kline French Lab Imidazo et pyrimido -(2,1-b)quinazolines, leurs procedes de preparationet compositions pharmaceutiques en contenant

Also Published As

Publication number Publication date
HU167227B (en, 2012) 1975-09-27
FI56012C (fi) 1979-11-12
DK152367C (da) 1988-07-25
NL7310776A (en, 2012) 1974-03-26
CH609348A5 (en) 1979-02-28
NL178165C (nl) 1986-02-03
DK152367B (da) 1988-02-22
FI56012B (fi) 1979-07-31
SE7310561L (en, 2012) 1974-03-25

Similar Documents

Publication Publication Date Title
NO140556C (no) Fremgangsmaate for fremstilling av n-fosfonometyl-glycin
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE382060B (sv) Forfarande for framstellning av nya substituerade piperidinoalkanonoximderivat
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
SE403106B (sv) Forfarande vid framstellning av 14-hydroximorfinanderivat
SE386892B (sv) Forfarande for framstellning av oxaminoforeningar
SE385698B (sv) Forfarande for framstellning av kinolinettiksyraderivat
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
SE399425B (sv) Forfarande for framstellning av 1-fenoxi-3-aminopropan-2-ol-derivat
SE399708B (sv) Forfarande for framstellning av tioxanton-2-karboxylsyraderivat
SE380803B (sv) Forfarande for framstellning av kondenserade piperazinderivat
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
SE393111B (sv) Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
SE400278B (sv) Forfarande for framstellning av fenylketonderivat
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE415355B (sv) Forfarande for framstellning av fosfonotioureider
SE393808B (sv) Forfarande for framstellning av isomaltit
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner
SE400086B (sv) Forfarande for framstellning av acylerade n(6)- aralkyl-adenosin-derivat
FI56670B (fi) Foerfarande foer framstaellning av 5-cyklohexyl-6-halogenindan-1-karboxylsyraderivat
SE403112B (sv) Analogiforfarande for framstellning av skopolaminderivat
NO144068C (no) Fremgangsmaate ved fremstilling av butyrofenonderivater
SE389862B (sv) Forfarande for framstellning av alfa-6-deoxitetracykliner